Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Asian J Endosc Surg ; 14(2): 207-212, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32789955

RESUMO

INTRODUCTION: Acute appendicitis is the commonest surgical emergency during pregnancy. The aim of this study is to evaluate the outcomes between antibiotic therapy and appendectomy in the management of uncomplicated appendicitis during gestation. METHODS: From January 2015 to April 2019, there were 2174 emergency appendicitis diagnosed in the University of Hong Kong-Shenzhen Hospital. Among them, 54 pregnant women were diagnosed with acute uncomplicated appendicitis and the clinical records were reviewed. Clinical demographics and outcomes including gestational age at delivery, mode of delivery, birth weight, APGAR score at 1 minute, fetal loss and overall length of stay were compared between the operation group and the antibiotic treatment group. RESULTS: The baseline characteristics showed no statistically significant difference between the two groups (P > .05). In the appendectomy group (n = 20), one patient had wound infection while none of the patients in the antibiotic therapy group (n = 34) experienced any complication. In the antibiotic treatment group, appendicitis recurred in one patient during pregnancy and in two patients after deliveries, which were all treated with appendectomy. The mean hospital stay of the antibiotic treatment group was shorter than that of the appendectomy group, but there was no significant difference (4.94 ± 2.6 days vs 6.25 ± 3.5 days, P = .540). There was no difference in gestational age at delivery, mode of delivery, birth weight and APGAR scores between the two groups (P > .05). CONCLUSIONS: For acute uncomplicated appendicitis during pregnancy, antibiotics treatment is a safe and feasible option.


Assuntos
Apendicite , Complicações na Gravidez , Doença Aguda , Antibacterianos/uso terapêutico , Apendicectomia , Apendicite/complicações , Apendicite/tratamento farmacológico , Apendicite/cirurgia , Feminino , Humanos , Tempo de Internação , Gravidez , Estudos Retrospectivos , Resultado do Tratamento
2.
Environ Toxicol Pharmacol ; 54: 120-124, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28704753

RESUMO

AIM: We investigated whether prostate fibrosis was associated with urinary dysfunction in chronic prostatitis (CP) and whether resveratrol improved urinary dysfunction and the underlying molecular mechanism. METHODS: Rat model of CP was established via subcutaneous injections of DPT vaccine and subsequently treated with resveratrol. Bladder pressure and volume tests investigated the effect of resveratrol on urinary dysfunction in CP rats. Western blotting and immunohistochemical staining examined the expression level of C-kit/SCF and TGF-ß/Wnt/ß-catenin. RESULTS: Compared to the control group, the maximum capacity of the bladder, residual urine volume and maximum voiding pressure, the activity of C-kit/SCF and TGF-ß/Wnt/ß-catenin pathways were increased significantly in the CP group. Resveratrol treatment significantly improved these factors. CONCLUSION: CP induced significantly prostate fibrosis, which exhibits a close relationship with urinary dysfunction. Resveratrol improved fibrosis, which may be associated with the suppression of C-kit/SCF and TGF-ß/Wnt/ß-catenin pathway.


Assuntos
Prostatite/tratamento farmacológico , Estilbenos/uso terapêutico , Bexiga Urinária Hiperativa/tratamento farmacológico , Animais , Doença Crônica , Fibrose , Masculino , Próstata/efeitos dos fármacos , Próstata/metabolismo , Próstata/patologia , Prostatite/metabolismo , Prostatite/patologia , Prostatite/fisiopatologia , Proteínas Proto-Oncogênicas c-kit/metabolismo , Ratos Sprague-Dawley , Resveratrol , Fator de Células-Tronco/metabolismo , Estilbenos/farmacologia , Fator de Crescimento Transformador beta/metabolismo , Bexiga Urinária Hiperativa/metabolismo , Bexiga Urinária Hiperativa/patologia , Bexiga Urinária Hiperativa/fisiopatologia , Proteínas Wnt/metabolismo , beta Catenina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA